Literature DB >> 18948305

Worsened long-term outcomes and postoperative complications in octogenarians with lung cancer following mediastinal lymph-node dissection.

Masayuki Chida1, Muneo Minowa, Yoko Karube, Syunsuke Eba, Yoshinori Okada, Shinichiro Miyoshi, Takashi Kondo.   

Abstract

We evaluated the effects of mediastinal lymph-node dissection on outcomes in octogenarians with primary lung cancer. Outcomes and postoperative complications were retrospectively investigated in 48 octogenarians with anatomically resected lung cancer, of whom 23 underwent a mediastinal lymph-node dissection (ND2 group) and 25 a limited lymphadenectomy (ND0-1 group). Forty-three patients underwent a lobectomy, two a pneumonectomy, and three a segmentectomy. The five-year survival rate for all was 35%, while that for those in pathological stage I was 43.3% and for those in stage II+III was 21.2%. As for lymph node dissection, the five-year survival rate for the ND0-1 group (54.3%) was superior to that for the ND2 group (21.7%) (P=0.022). For patients in pathological stage I, those rated ND0-1 had a better five-year survival than those rated ND2 (61.9% vs. 28.6%) (P=0.041). In addition, mediastinal lymph-node dissection increased the incidence of postoperative cardiac complications (P=0.004). Our results indicate that major pulmonary resection with mediastinal lymph-node dissection is associated with a higher rate of mortality in octogenarians with lung cancer.

Entities:  

Mesh:

Year:  2008        PMID: 18948305     DOI: 10.1510/icvts.2008.193383

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  9 in total

1.  Surgery or stereotactic body radiotherapy for elderly stage I lung cancer? A propensity score matching analysis.

Authors:  Takuro Miyazaki; Takuya Yamazaki; Daisuke Nakamura; Shuntaro Sato; Naoya Yamasaki; Tomoshi Tsuchiya; Keitaro Matsumoto; Ryotaro Kamohara; Go Hatachi; Takeshi Nagayasu
Journal:  Surg Today       Date:  2017-04-26       Impact factor: 2.549

Review 2.  Surgical treatment of non-small-cell lung cancer in octogenarians.

Authors:  Miguel Guerra; Paulo Neves; José Miranda
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-02-08

3.  A lobe-specific lymphadenectomy protocol for solitary pulmonary nodules in non-small cell lung cancer.

Authors:  Xue-Ning Yang; Ze-Rui Zhao; Wen-Zhao Zhong; Qiang Nie; Ri-Qiang Liao; Song Dong
Journal:  Chin J Cancer Res       Date:  2015-12       Impact factor: 5.087

Review 4.  Treatment strategy and decision-making for elderly surgical candidates with early lung cancer.

Authors:  Jiro Okami
Journal:  J Thorac Dis       Date:  2019-04       Impact factor: 2.895

5.  Results of Lung Cancer Surgery for Octogenarians.

Authors:  Haruaki Hino; Tomohiro Murakawa; Junji Ichinose; Kazuhiro Nagayama; Junichi Nitadori; Masaki Anraku; Jun Nakajima
Journal:  Ann Thorac Cardiovasc Surg       Date:  2015-03-16       Impact factor: 1.520

6.  Significance of Body Mass Index for Postoperative Outcomes after Lung Cancer Surgery in Elderly Patients.

Authors:  Katsunari Matsuoka; Tetsu Yamada; Takahisa Matsuoka; Shinjiro Nagai; Mitsuhiro Ueda; Yoshihiro Miyamoto
Journal:  World J Surg       Date:  2018-01       Impact factor: 3.352

Review 7.  Sampling versus systematic full lymphatic dissection in surgical treatment of non-small cell lung cancer.

Authors:  Georgios Koulaxouzidis; Grigorios Karagkiouzis; Marios Konstantinou; Ioannis Gkiozos; Konstantinos Syrigos
Journal:  Oncol Rev       Date:  2013-06-18

8.  Assessing Survival and Grading the Severity of Complications in Octogenarians Undergoing Pulmonary Lobectomy.

Authors:  Andrew Feczko; Elizabeth McKeown; Jennifer L Wilson; Brian E Louie; Ralph W Aye; Jed A Gorden; Eric Vallières; Alexander S Farivar
Journal:  Can Respir J       Date:  2017-02-08       Impact factor: 2.409

9.  Prognostic nutritional index may not be a good prognostic indicator for acute myocardial infarction.

Authors:  Yisong Cheng; Hong Li; Dongze Li; Lianjing Liang; Yu Jia; Liqun Zou; Fanghui Li; Xingyu Zhu; Hong Qian; Na He; Zhi Zeng; Rui Zeng; Yu Cao; Zhi Wan
Journal:  Sci Rep       Date:  2019-10-11       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.